Cornerstone Planning Group’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-220
Closed -$9.6K – 1454
2026
Q2
$9.6K Sell
220
-16
-7% -$715 ﹤0.01% 903
2026
Q1
$10.2K Buy
236
+23
+11% +$1.07K ﹤0.01% 884
2025
Q4
$9.7K Sell
213
-160
-43% -$7.93K ﹤0.01% 807
2025
Q3
$96.7K Buy
373
+264
+242% +$12.7K 0.02% 215
2025
Q2
$5.22K Sell
109
-96
-47% -$4.9K ﹤0.01% 717
2025
Q1
$10.9K Buy
205
+6
+3% +$325 ﹤0.01% 549
2024
Q4
$10.6K Buy
199
+15
+8% +$763 ﹤0.01% 421
2024
Q3
$9.9K Sell
184
-109
-37% -$5.88K ﹤0.01% 412
2024
Q2
$15.1K Buy
293
+51
+21% +$2.46K ﹤0.01% 364
2024
Q1
$11.9K Sell
242
-10
-4% -$488 ﹤0.01% 376
2023
Q4
$12.5K Sell
252
-16
-6% -$782 ﹤0.01% 392
2023
Q3
$14.4K Sell
268
-22
-8% -$1.17K 0.01% 352
2023
Q2
$15.6K Buy
+290
New +$15.6K 0.01% 496
2022
Q4
$7.52K Buy
+152
New +$6.67K ﹤0.01% 734

Other funds holding SNY

Cornerstone Planning Group's SNY Position: Q3 2026 in Review

Cornerstone Planning Group sold out of Sanofi (SNY) in Q3 2026, closing a stake of 220 shares — an estimated $9.6K sold.

Cornerstone Planning Group first reported a position in SNY in Q4 2022 and held it in 14 quarters. The position peaked at $96.7K in Q3 2025. 160 funds tracked by Wall St. Rank hold SNY as of Q3 2026.

  • Cornerstone Planning Group reported no remaining Sanofi position as of Q3 2026 after selling out during the quarter.
  • Cornerstone Planning Group sold 220 Sanofi shares in Q3 2026, an estimated $9.6K.
  • Cornerstone Planning Group first reported a position in Sanofi in Q4 2022 and held it in 14 quarters.
  • Cornerstone Planning Group's Sanofi position peaked at $96.7K in Q3 2025.
  • 160 funds tracked by Wall St. Rank held Sanofi as of Q3 2026.

Based on Cornerstone Planning Group's 13F filing for Q3 2026, filed 16 Oct 2026.